ANNX Statistics

Total Valuation

Annexin Pharmaceuticals AB has a market cap or net worth of SEK 257.43 million. The enterprise value is 231.79 million.

Market Cap	257.43M
Enterprise Value	231.79M

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Annexin Pharmaceuticals AB has 532.98 million shares outstanding. The number of shares has increased by 130.52% in one year.

Current Share Class	n/a
Shares Outstanding	532.98M
Shares Change (YoY)	+130.52%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	46.79%
Owned by Institutions (%)	3.08%
Float	274.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	10.26
P/TBV Ratio	10.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.42
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.66

Current Ratio	7.66
Quick Ratio	7.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -407.85% and return on invested capital (ROIC) is -184.36%.

Return on Equity (ROE)	-407.85%
Return on Assets (ROA)	-147.71%
Return on Capital (ROIC)	-184.36%
Revenue Per Employee	n/a
Profits Per Employee	-13.11M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +86.80% in the last 52 weeks. The beta is 1.09, so Annexin Pharmaceuticals AB's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	+86.80%
50-Day Moving Average	0.51
200-Day Moving Average	0.47
Relative Strength Index (RSI)	46.89
Average Volume (20 Days)	132,554

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.68M
Pretax Income	-52.45M
Net Income	-52.45M
EBITDA	-52.49M
EBIT	-52.68M
Earnings Per Share (EPS)	-0.14

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	25.64M
Total Debt	n/a
Net Cash	25.64M
Net Cash Per Share	0.05
Equity (Book Value)	25.09M
Book Value Per Share	0.05
Working Capital	23.38M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-52.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Annexin Pharmaceuticals AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-130.52%
Shareholder Yield	-130.52%
Earnings Yield	-29.78%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a